Literature DB >> 2420404

Prostaglandin E receptor subtypes in smooth muscle: agonist activities of stable prostacyclin analogues.

Y J Dong, R L Jones, N H Wilson.   

Abstract

The agonist activities of a range of prostaglandin analogues on smooth muscle preparations sensitive to prostaglandin E2 (PGE2) have been investigated. When necessary thromboxane-like activity was eliminated using the thromboxane receptor antagonists EP 045 and EP 092. On the bullock iris sphincter, rat stomach fundus and guinea-pig trachea, (+/-) omega-tetranor-16-p-chlorophenoxy PGE2 (ICI 80205) and 16,16-dimethyl PGE2 were more active contractile agents than PGE2, whereas for relaxant activity on the cat trachea, guinea-pig trachea and dog hind limb arterial vessels in vivo the order of potency was reversed. 11-Deoxy PGE1 exhibited greater relaxant than contractile activity when compared to PGE2. Iloprost and 6a-carba-delta 6,6aPGI1 (potent mimetics of PGI2) showed high contractile activity on the PGE-sensitive preparations. PGI2 was less active and another potent PGI2 mimetic, ZK 96480, showed only very weak activity. When tested, the dibenzoxazepines SC 19220 and SC 25191 blocked the contractile actions of iloprost and 6a-carba-delta 6,6aPGI1 and those of PGE2 and 16,16-dimethyl PGE2 to similar extents. Each of the PGI2 analogues showed weak activity on the relaxant systems. On the proximal portion of the ascending colon of the rat, PGI2, iloprost, 6a-carba-delta 6,6aPGI1 and ZK 96480 always inhibited spontaneous activity at nanomolar concentrations. PGE2 and PGE1 showed weak contractile activity. The distal portion of the ascending colon was more responsive to the contractile action of PGE analogues: both iloprost and 6a-carba-delta 6,6aPGI1 showed evidence of contractile activity, whereas PGI2 and ZK 96480 always inhibited spontaneous activity. Evidence was obtained that the rat stomach fundus also contains a PGF receptor; (+/-) omega-tetranor-16-m-trifluoromethylphenoxy PGF2 alpha (ICI 81008) acted as a specific agonist. PGF2 alpha and its omega-tetranor-16-p-fluorophenoxy analogue produced a higher maximum response that ICI 81008 probably due to their additional agonist action at the PGE receptor. The data support the hypothesis that there are two subtypes of the PGE receptor. ZK 96480 has minimal activity on both receptor subtypes and appears to be a highly specific PGI2 mimetic.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2420404      PMCID: PMC1916898          DOI: 10.1111/j.1476-5381.1986.tb10161.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  14 in total

Review 1.  Prostaglandin endoperoxide and thromboxane A2 analogs.

Authors:  N H Wilson; R L Jones
Journal:  Adv Prostaglandin Thromboxane Leukot Res       Date:  1985

2.  Studies on the characterization of prostanoid receptors.

Authors:  I Kennedy; R A Coleman; P P Humphrey; P Lumley
Journal:  Adv Prostaglandin Thromboxane Leukot Res       Date:  1983

3.  Comparison of the potencies of some prostaglandins as vasodilators in three vascular beds of the anaesthetised dog.

Authors:  P Lumley; P P Humphrey; I Kennedy; R A Coleman
Journal:  Eur J Pharmacol       Date:  1982-07-16       Impact factor: 4.432

4.  Competitive antagonism at thromboxane receptors in human platelets.

Authors:  R A Armstrong; R L Jones; V Peesapati; S G Will; N H Wilson
Journal:  Br J Pharmacol       Date:  1985-03       Impact factor: 8.739

5.  Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides.

Authors:  R J Gryglewski; S Bunting; S Moncada; R J Flower; J R Vane
Journal:  Prostaglandins       Date:  1976-11

6.  Actions of 16-aryloxy analogues of prostaglandin F2alpha on preparations responsive to prostaglandin endoperoxides.

Authors:  R L Jones; C G Marr
Journal:  Br J Pharmacol       Date:  1977-12       Impact factor: 8.739

7.  Prostaglandin E2 and the bovine sphincter pupillae.

Authors:  J Posner
Journal:  Br J Pharmacol       Date:  1973-11       Impact factor: 8.739

8.  Studies on prostaglandin antagonists.

Authors:  A Bennett; J Posner
Journal:  Br J Pharmacol       Date:  1971-08       Impact factor: 8.739

9.  Specific receptors for prostaglandins in airways.

Authors:  P J Gardiner; H O Collier
Journal:  Prostaglandins       Date:  1980-06

10.  Comparison of the vasodepressor action of ZK 36 374, a stable prostacyclin derivative, PGI2 and PGE1 with their effect on platelet aggregation and bleeding time in rats.

Authors:  J Casals-Stenzel; M Buse; W Losert
Journal:  Prostaglandins Leukot Med       Date:  1983-02
View more
  43 in total

1.  Classification of platelet and vascular prostaglandin D2 (DP) receptors: estimation of affinities and relative efficacies for a series of novel bicyclic ligands. With an appendix on goodness-of-fit analyses.

Authors:  P Leff; H Giles
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

2.  Regulation of prostacyclin and prostaglandin E(2) receptor mediated responses in adult rat dorsal root ganglion cells, in vitro.

Authors:  D K Rowlands; C Kao; H Wise
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

3.  Proceedings of the British Pharmacological Society. University of Manchester, 13-15 September 1989.

Authors: 
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

4.  Non-prostanoid prostacyclin mimetics as neuronal stimulants in the rat: comparison of vagus nerve and NANC innervation of the colon.

Authors:  J A Rudd; Y m Qian; K K Tsui; R L Jones
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

5.  Augmentation of allergic inflammation in prostanoid IP receptor deficient mice.

Authors:  Yoshimasa Takahashi; Shota Tokuoka; Taisei Masuda; Yousuke Hirano; Masafumi Nagao; Hiroyuki Tanaka; Naoki Inagaki; Shuh Narumiya; Hiroichi Nagai
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

6.  Characterization of the prostanoid receptor profile of enprostil and isomers in smooth muscle and platelets in vitro.

Authors:  R M Eglen; R L Whiting
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

7.  Characterization of the prostaglandin E2 sensitive (EP)-receptor in the rat isolated trachea.

Authors:  S J Lydford; K McKechnie
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

8.  Inhibition of rat colon contractility by prostacyclin (IP-) receptor agonists: involvement of NANC neurotransmission.

Authors:  Y M Qian; R L Jones
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

9.  Inhibition of vagally mediated gastric acid secretion by activation of central prostanoid EP3 receptors in urethane-anaesthetized rats.

Authors:  K Yokotani; Y Okuma; Y Osumi
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

Review 10.  Prostanoid receptor antagonists: development strategies and therapeutic applications.

Authors:  R L Jones; M A Giembycz; D F Woodward
Journal:  Br J Pharmacol       Date:  2009-07-15       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.